Ginsenoside Rd promote the contact between mitochondria and lipid droplets through Plin1/Mfn2 to treat diabetic kidney disease

Figure 1 Treatment of diabetic kidney disease symptoms in db/db mice with ginsenoside Rd. A: Animal experimental process; B: Weekly recorded weight (n = 6); C: The last weight chart (n = 6); D: Fasting blood glucose levels (n = 6); E: Blood glucose changes in the Glucose Tolerance Test (n = 6); F: Average area under Glucose Tolerance Test curve (n = 6); G: Blood glucose changes in the Insulin Tolerance Test (n = 6); H: Average area under Insulin Tolerance Test curve (n = 6); I: Creatinine in blood serum (n = 4); J: Creatinine clearance rate (n = 4); K: Urinary albumin-to-creatinine ratio (n = 4). Data are presented as mean ± SEM. ^aP < 0.01 compared with control group; ^bP < 0.01 compared with model group. AUC: Area under the curve.